What you need to know for the year ahead.
By Paul Girouard
As we look ahead to 2026, the infection prevention category remains one of the most vital and resilient segments in the medical-surgical market. From gloves and hand hygiene to vaccines and sterilization systems, these products are essential across every care setting. With continued growth projected and a steady stream of innovation, infection prevention is no longer viewed as just a cost of doing business – it’s a strategic investment in safety, quality, and operational efficiency. For new sales reps, this category presents an exciting opportunity to make a meaningful impact while building strong, solution-driven relationships with customers.
Why this category matters in 2026
- Healthcare acquired infections (HAIs) continue to cost hospitals serious money, both in patient outcomes and regulatory risk.
- More care is happening in outpatient, ambulatory surgery centers (ASCs) and home health settings, so IP opportunities are found throughout healthcare.
- Innovation is accelerating: think antimicrobial coatings, more advanced sterilization technology, single use instruments, smarter PPE.
- Sustainability and supply chain resilience are now buyer priorities: fewer vendors just selling bundles, more selling value and reliability.
Category by category snapshot
Gloves: They represent the largest piece of the category. And thanks to rising procedure volumes and broader IP awareness, the global gloves market is trending upward. According to Grand View Research this product segment is growing at an estimated 8.5%. Comfort and quality matter. Remember that your customers spend a great deal of time wearing gloves; they notice and are vocal on what works for them.
Hand hygiene: If you’re skipping this, you’re missing a conversational entry point. Hand hygiene is the foundation of most infection prevention programs. The best reps tie hygiene products to compliance, cost avoidance, patient safety and workflow.
Surface disinfection and instrument sterilization: As care expands into non traditional settings, so does the need for robust cleaning protocols and sterilization workflows. Surface wipes continue to improve with new formulations, killing more pathogens, more quickly.
PPE and face masks: Respiratory risk, procedure risk, and evolving pathogens mean PPE remains a high priority. “General PPE” market data also supports strong growth. According to one study it was estimated to be a $91.5 billion market in 2025.
Safety needles/syringes: Less flashy maybe, but crucial. Sharps injury prevention, regulatory mandates, and growing outpatient/injection volume make this segment relevant.
Vaccines: Often treated separately, but from an IP lens they’re foundational. Reps who align their product story with vaccine support add value.
What this means for a distribution sales representative
You’re not just moving boxes, you’re solving problems. Here’s how to step up:
- Speak outcomes: Instead of “Here are gloves,” say “Here’s how you reduce cross contamination, protect staff and avoid cost of infection.”
- Bundle smart: Offer a combination of gloves + hand hygiene + surface disinfection to become a partner, not just a vendor.
- Use data and stories: Point to market growth and compliance pressure when you talk to buyers.
- Bring training and service: Be the rep who offers an in-service, a refresher for staff, a checklist for hand hygiene compliance.
- Stay ahead of technology and regulation: Know what’s changing (e.g., regulations, sustainability mandates, outpatient care expansion).
What to keep an eye on in 2026
New regulatory guidance around infection prevention in outpatient/ASC settings and home health.
Procurement shifts toward value and outcomes. Buyers want more than price, they want reliability, service, and measurable results.
Outbreak readiness and emerging pathogen risk will keep IP spending relevant beyond routine procurement.
Sustainability will become a selling point – not a nice to have – so eco friendly materials, recyclable packaging and supply chain transparency will matter.
Bottom line
The infection prevention category for 2026 offers you a strong runway. If you sell it like it matters and help your customers, see how it does – you’ll win more calls, build deeper relationships, and position yourself as a trusted partner in safer care. That’s how you move from tactical to strategic solution selling.
Wash your hands.